Grant: Discovery Grants Program - Individual
The University of British Columbia
$36,000.00
New Radical and Fluorination Methods for the Syntheses of Pharmaceuticals
FY 2023-24
Summary
Summary of Proposal: This research proposal focuses on the discovery of innovative synthetic organic methods with a focus on developing new bond formation technologies for which there are currently no alternative. We plan to explore two main themes: (A) new applications of commodity chemicals in synthetic processes and (B) new single electron processes for the synthesis of pharmaceutically- and agrochemically-relevant motifs. For the first theme, we will continue to explore the use of sulfuryl fluoride (SO2F2), an industrial fumigant. We have found that SO2F2 can be used to enable multi-step reactions in a single reaction pot. This grant describes our future exploration of the development of new sulfuryl fluoride-mediated reactions for which there are currently no competitive one-pot alternatives. We will also examine the synthesis of new SO2F2-based reagents for pharmaceutically-relevant reactions. These methods are anticipated to enable greater efficiency and, thus lower the cost, of pharmaceutical and agrochemical production. The second theme (B), based on single electron processes, is subdivided into three main areas. First, we will explore applications of a recent breakthrough from my laboratory on the synthesis of chiral 1,4-diamines, which are laborious to synthesize using existing technology. We plan to prepare a small library of these relatively underexplored chiral 1,4-diamines and explore their use both as motifs in chiral ligands for pharmaceutical production as well as components of protease inhibitors for use in the treatment of HIV. Second, we will explore new strategies for enantioselective radical cyclizations, an area that has very few solutions. The strategy that we will explore utilizes a key Lewis acid-accelerated single electron reduction to promote selective radical formation and cyclization. Success in this area will provide new, efficient synthetic routes to pharmaceuticals. Finally, we will explore new radical fluorine trapping agents for use in synthesis. Fluorine is ubiquitous in modern pharmaceuticals, and any new developments help cut the cost of existing medications and allow the study of new ones. We recently discovered that existing electrophilic fluorination reagents can be applied to single electron processes. This discovery has created a new field of synthetic fluorination. Despite the success of these reagents, the rate of fluorine transfer for these reagents is not sufficiently fast to trap many highly reactive species. This proposal outlines the exploration of a new class of C-F radical transfer agents and explores their use in transformations that are not currently possible using existing synthetic technology.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-04653
Name nom
Sammis, Glenn
Department département
Chemistry - Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Synthetic methodology
Research subject en
Chimie organique
Research subject fr
Méthodologie en synthèse
Application title
New Radical and Fluorination Methods for the Syntheses of Pharmaceuticals
Keyword
Asymmetric catalysis; Diamine Ligands; Fluorination; Fluoroalkylation; Free Radicals; Heterocycles; HIV Protease Inhibitors; Single Electron Reductions; Sulfuryl fluoride; Synthetic Methods
Application summary
Summary of Proposal: This research proposal focuses on the discovery of innovative synthetic organic methods with a focus on developing new bond formation technologies for which there are currently no alternative. We plan to explore two main themes: (A) new applications of commodity chemicals in synthetic processes and (B) new single electron processes for the synthesis of pharmaceutically- and agrochemically-relevant motifs. For the first theme, we will continue to explore the use of sulfuryl fluoride (SO2F2), an industrial fumigant. We have found that SO2F2 can be used to enable multi-step reactions in a single reaction pot. This grant describes our future exploration of the development of new sulfuryl fluoride-mediated reactions for which there are currently no competitive one-pot alternatives. We will also examine the synthesis of new SO2F2-based reagents for pharmaceutically-relevant reactions. These methods are anticipated to enable greater efficiency and, thus lower the cost, of pharmaceutical and agrochemical production. The second theme (B), based on single electron processes, is subdivided into three main areas. First, we will explore applications of a recent breakthrough from my laboratory on the synthesis of chiral 1,4-diamines, which are laborious to synthesize using existing technology. We plan to prepare a small library of these relatively underexplored chiral 1,4-diamines and explore their use both as motifs in chiral ligands for pharmaceutical production as well as components of protease inhibitors for use in the treatment of HIV. Second, we will explore new strategies for enantioselective radical cyclizations, an area that has very few solutions. The strategy that we will explore utilizes a key Lewis acid-accelerated single electron reduction to promote selective radical formation and cyclization. Success in this area will provide new, efficient synthetic routes to pharmaceuticals. Finally, we will explore new radical fluorine trapping agents for use in synthesis. Fluorine is ubiquitous in modern pharmaceuticals, and any new developments help cut the cost of existing medications and allow the study of new ones. We recently discovered that existing electrophilic fluorination reagents can be applied to single electron processes. This discovery has created a new field of synthetic fluorination. Despite the success of these reagents, the rate of fluorine transfer for these reagents is not sufficiently fast to trap many highly reactive species. This proposal outlines the exploration of a new class of C-F radical transfer agents and explores their use in transformations that are not currently possible using existing synthetic technology.